| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Lipocine Inc. (LPCN) has 3 insiders with recent SEC Form 4 filings, including 8 buys and 7 sells. LPCN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 203.8K | $462.6K | - | |
| CEO | 160.7K | $364.7K | - | |
| Other | 40.1K | $91.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 10, 2019 | Patel Mahesh V. | President And CEO | Buy | 25,000 | $0.40 | $9,975.00 | +2.8% | |
| Dec 4, 2019 | Brown Morgan R | EVP And Chief Financial Office | Sale+OE | 17,250 | $0.41 | $7,075.95 | -21.3% | |
| Dec 4, 2019 | Patel Mahesh V. | CEO And President | Sale+OE | 43,500 | $0.41 | $17,835.00 | -4.6% | |
| Nov 26, 2019 | Patel Mahesh V. | President And CEO | Buy | 25,000 | $0.43 | $10,696.01 | +0.8% | |
| Nov 18, 2019 | Patel Mahesh V. | CEO And President | Buy | 50,000 | $0.40 | $20,094.74 | +2.2% | |
| Dec 29, 2017 | Ono Richard Dana | Director | Sale+OE | 875 | $3.47 | $3,033.36 | -15.2% | |
| Dec 29, 2017 | Fink Jeffrey Arvin | Director | Sale+OE | 938 | $3.47 | $3,258.33 | -50.0% | |
| Dec 29, 2017 | Bass Gregory Brooks | Chief Commercial Officer | Sale+OE | 3,750 | $3.47 | $13,023.38 | -40.0% | |
| Dec 29, 2017 | Patel Mahesh V. | CEO, President | Sale+OE | 6,000 | $3.48 | $20,866.80 | -0.8% | |
| Dec 29, 2017 | Brown Morgan R | EVP And CFO | Sale+OE | 2,813 | $3.47 | $9,773.49 | -10.7% |